Junko Tanaka

Eng koʻp iqtibos qilingan asarlar

1. Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers20221 iqtibos
2. Eighteen‐year follow‐up cohort study on hepatitis B and C virus infections related long‐term prognosis among hemodialysis patients in Hiroshima20200 iqtibos
3. Variant-specific Symptoms After COVID-19: A Hospital-based Study in Hiroshima20230 iqtibos
4. Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers20230 iqtibos
5. Development of a unit conversion tool for five quantitative anti‐spike assays and agreement analysis of three qualitative anti‐nucleocapsid assays for SARS‐CoV‐220240 iqtibos
6. Assessing the diagnostic accuracy of serological tests for hepatitis delta virus diagnosis: a systematic review and meta-analysis20240 iqtibos
7. Intermediate hepatitis C virus (HCV) endemicity and its genotype distribution in Myanmar: A systematic review and meta-analysis20240 iqtibos
8. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies20250 iqtibos
9. Weighted prevalence and associated risk factors of hepatitis E virus antibodies among pregnant women in rural Burkina Faso using dried blood spot samples20250 iqtibos

Hammualliflar

1. Ko Ko8 ta umumiy asar2020–2025
2. Tomoyuki Akita8 ta umumiy asar2020–2025
3. Aya Sugiyama7 ta umumiy asar2022–2025
4. Serge Ouoba6 ta umumiy asar2022–2025
5. Ulugbek Khudayberdievich Mirzaev6 ta umumiy asar2020–2025
6. Kazuaki Takahashi4 ta umumiy asar2020–2025
7. Zayar Phyo4 ta umumiy asar2024–2025
8. Akemi Kurisu4 ta umumiy asar2022–2024
9. Kanon Abe4 ta umumiy asar2022–2024
10. Golda Ataa Akuffo3 ta umumiy asar2024–2025

Barcha hammualliflar →